Work

Abstract B21: Identifying mechanisms of resistance to BET bromodomain inhibition.

Year: 2015

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.hemmal14-b21

Authors: Richard C. Centore, Charlie Hatton, Barbara Bryant, Robert J. Sims

Institution: Constellation Pharmaceuticals (United States)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2354854188

Cites:

Cited by:

Related to: 10